IRS1
Insulin receptor substrate 1
Also known as: HIRS-1, IRS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35568
- Gene
- IRS1
- Ensembl
- ENSG00000169047
- Chromosome
- 2
- Canonical length
- 1242 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
1242 residues, UniProt reviewed canonical sequence.
>P35568|IRS1
1 MASPPESDGF SDVRKVGYLR KPKSMHKRFF VLRAASEAGG PARLEYYENE KKWRHKSSAP
61 KRSIPLESCF NINKRADSKN KHLVALYTRD EHFAIAADSE AEQDSWYQAL LQLHNRAKGH
121 HDGAAALGAG GGGGSCSGSS GLGEAGEDLS YGDVPPGPAF KEVWQVILKP KGLGQTKNLI
181 GIYRLCLTSK TISFVKLNSE AAAVVLQLMN IRRCGHSENF FFIEVGRSAV TGPGEFWMQV
241 DDSVVAQNMH ETILEAMRAM SDEFRPRSKS QSSSNCSNPI SVPLRRHHLN NPPPSQVGLT
301 RRSRTESITA TSPASMVGGK PGSFRVRASS DGEGTMSRPA SVDGSPVSPS TNRTHAHRHR
361 GSARLHPPLN HSRSIPMPAS RCSPSATSPV SLSSSSTSGH GSTSDCLFPR RSSASVSGSP
421 SDGGFISSDE YGSSPCDFRS SFRSVTPDSL GHTPPARGEE ELSNYICMGG KGPSTLTAPN
481 GHYILSRGGN GHRCTPGTGL GTSPALAGDE AASAADLDNR FRKRTHSAGT SPTITHQKTP
541 SQSSVASIEE YTEMMPAYPP GGGSGGRLPG HRHSAFVPTR SYPEEGLEMH PLERRGGHHR
601 PDSSTLHTDD GYMPMSPGVA PVPSGRKGSG DYMPMSPKSV SAPQQIINPI RRHPQRVDPN
661 GYMMMSPSGG CSPDIGGGPS SSSSSSNAVP SGTSYGKLWT NGVGGHHSHV LPHPKPPVES
721 SGGKLLPCTG DYMNMSPVGD SNTSSPSDCY YGPEDPQHKP VLSYYSLPRS FKHTQRPGEP
781 EEGARHQHLR LSTSSGRLLY AATADDSSSS TSSDSLGGGY CGARLEPSLP HPHHQVLQPH
841 LPRKVDTAAQ TNSRLARPTR LSLGDPKAST LPRAREQQQQ QQPLLHPPEP KSPGEYVNIE
901 FGSDQSGYLS GPVAFHSSPS VRCPSQLQPA PREEETGTEE YMKMDLGPGR RAAWQESTGV
961 EMGRLGPAPP GAASICRPTR AVPSSRGDYM TMQMSCPRQS YVDTSPAAPV SYADMRTGIA
1021 AEEVSLPRAT MAAASSSSAA SASPTGPQGA AELAAHSSLL GGPQGPGGMS AFTRVNLSPN
1081 RNQSAKVIRA DPQGCRRRHS SETFSSTPSA TRVGNTVPFG AGAAVGGGGG SSSSSEDVKR
1141 HSSASFENVW LRPGELGGAP KEPAKLCGAA GGLENGLNYI DLDLVKDFKQ CPQECTPEPQ
1201 PPPPPPPHQP LGSGESSSTR RSSEDLSAYA SISFQKQPED RQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 26 nTPM
- ovary: 20 nTPM
- thyroid gland: 19 nTPM
- endometrium: 16 nTPM
- fallopian tube: 14 nTPM
- cervix: 13 nTPM
Single-cell type
- adipocytes: 166 nCPM
- renal collecting duct intercalated cells: 138 nCPM
- adrenal cortex cells: 122 nCPM
- breast lactating cells: 120 nCPM
- platelets: 99 nCPM
- hepatocytes: 97 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 18 nTPM
- cerebral cortex: 14 nTPM
- spinal cord: 12 nTPM
- medulla oblongata: 11 nTPM
- basal ganglia: 11 nTPM
- choroid plexus: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IRS1.
Disease | AllUniProt
Conditions IRS1 is implicated in, by any mechanism.
- Type 2 diabetes mellitus (T2D) MIM:125853
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 206 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to fatty acid
- cellular response to insulin stimulus
- cytokine-mediated signaling pathway
- glucose homeostasis
- insulin receptor signaling pathway
- insulin-like growth factor receptor signaling pathway
- negative regulation of insulin receptor signaling pathway
- negative regulation of insulin secretion
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of cell population proliferation
- positive regulation of D-glucose import
- positive regulation of fatty acid beta-oxidation
- positive regulation of glucose metabolic process
- positive regulation of glycogen biosynthetic process
- positive regulation of insulin receptor signaling pathway
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- response to insulin
- signal transduction
Molecular functions
- insulin receptor binding
- insulin-like growth factor receptor binding
- phosphatidylinositol 3-kinase binding
- phosphotyrosine residue binding
- protein kinase C binding
- SH2 domain binding
- signaling adaptor activity
- signaling receptor complex adaptor activity
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRS1 as an antibody target. Whether an autoantibody or antibody against IRS1 could matter depends on whether native IRS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IRS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...